Medical/Pharmaceuticals
Hummingbird Bioscience Announces Trial in Progress Poster Presentation at the European Society for Medical Oncology Congress 2022
* HMBD-001 is a proprietary anti-HER3 antibody in an ongoing Phase 1 trial targeting multiple solid tumors * HMBD-001 has the potential to fully block both ligand-dependent and -independent HER3 signaling SINGAPORE, Sept. 8, 2022 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision...
2022-09-08 20:00
2773
ONE DRUG FOR ONE BUG: DEBIOPHARM TO DISCUSS THE POTENTIAL OF PATHOGEN-SPECIFIC ANTIBIOTICS AT THE 2022 WORLD AMR CONGRESS
* International health authorities, such as the WHO and the CDC are warning of the emerging danger of bacterial infections resistant to current antibiotics * The 2022 World Anti-Microbial Resistance (AMR) Congress in the greater Washington D.C. area is serving as a forum to openly address the ...
2022-09-08 16:41
2421
NeuroXess Attends WAIC with its First Medical-Grade BCI Product Pipeline
SHANGHAI, Sept. 8, 2022 /PRNewswire/ -- The Brain Sciences Theme Forum of 2022 World Artificial Intelligence Conference (WAIC) was held at Shanghai World Exhibition and Convention Center onSeptember 2. NeuroXess, a China-based high-tech life science company focusing on flexible electrode BCI (br...
2022-09-08 16:19
2790
Cytiva launches BioChallenge in Southeast Asia to support biotech startup development
* Cytiva's BioChallenge launches in Singapore, Indonesia, Thailand and Vietnam to accelerate the growth of promising emerging biotechs * BioChallenge facilitates access to Cytiva's services and expertise to scale up efficiently, mitigate risks and reduce time to go to market * Application pe...
2022-09-08 15:31
3282
The Outbreak of COVID-19 Unlocked the Demand for Antimicrobial Technologies
Innovations triggered by the pandemic are pushing industries to adopt long-lasting antimicrobial technology, says Frost & Sullivan SAN ANTONIO, Sept. 8, 2022 /PRNewswire/ -- The outbreak of COVID-19 unlocked the demand for antimicrobial technologies across sectors, finds Frost & Sullivan's recen...
2022-09-08 15:12
2366
Innovent's Sintilimab plus Chemotherapy Demonstrated PFS Benefit in Patients with EGFR-mutated Non-Squamous Non-Small Cell Lung Cancer in the Second Interim Analysis Results of the ORIENT-31 Study
ROCKVILLE, Md. and SUZHOU, China, Sept. 8, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology...
2022-09-08 08:05
4833
Sangel Capital Founder Receives Title of China's Top Early-Stage Investor from ChinaVenture Awards
SHENZHEN, China, Sept. 7, 2022 /PRNewswire/ -- Sangel Capital ("Sangel" or the "Company"), a leading biotech and healthcare venture capital company based in China, has announced that Liu Mulong, Founding Partner with the Company, has been awarded as one ofChina's top early-stage investors of 2021 ...
2022-09-07 23:30
3974
Global study shows Artificial Intelligence can reduce time to pregnancy for IVF couples by 12%
SAN FRANCISCO, Sept. 7, 2022 /PRNewswire/ -- Reproductive BioMedicine Online (RBMO) journal has published results of an international clinical study BY Presagen showing that its Artificial Intelligence (AI) product Life Whisperer can reduce time to pregnancy for IVF couples by 12%, potentially sa...
2022-09-07 21:07
2742
Pulnovo Medical Limited's PADN Technology Included in 2022 ESC/ERS Guidelines for the Diagnosis and Treatment of PH
SHANGHAI, Sept. 7, 2022 /PRNewswire/ -- A globally recognized OTM innovative
platform Pulnovo Medical
2022-09-07 20:30
4129
Australian company developing cutting edge training for Defence medics using virtual reality and biometrics
MELBOURNE, Australia, Sept. 7, 2022 /PRNewswire/ -- Australian first responder training company Real Response has created breakthrough software with support from Defence to enhance tactical and combat medical training. The system uses virtual reality and live biometric data to provide medics with...
2022-09-07 16:15
4364
TikoMed's drug candidate ILB® inhibited infection of human cells by Dengue, Zika and Yellow Fever viruses in vitro, providing further support for its broad spectrum mechanism of action
VIKEN, Sweden, Sept. 7, 2022 /PRNewswire/ -- TikoMed today announced the inclusion in bioRxiv* of an in vitro study examining the ability of the company's lead drug candidate ILB® to inhibit infection of human cells by four serotypes of Dengue virus (DENV1-4), two strains of Zika virus (African a...
2022-09-07 14:32
3327
Prolonging healthspan by delaying ageing -- NUHS opens Singapore's first Centre for Healthy Longevity to increase healthy lifespan of Singapore population by five more disease-free years
The National University Health System (NUHS) establishes the NUHS Centre for
Healthy Longevity
2022-09-07 13:00
5155
Sirnaomics to Present at 3rd Annual Jefferies Asia Forum
GAITHERSBURG, Md. and SUZHOU, China, Sept. 7, 2022 /PRNewswire/ -- Sirnaomics Ltd.(the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that Dr.Patrick Lu, PhD, founder, Chairman of the Board, ...
2022-09-07 11:32
4222
Non-invasive skin immune biomarker test helps predict development of eczema in babies, new study presented at the EADV Congress finds
MILAN, Sept. 7, 2022 /PRNewswire/ -- Researchers have identified an immune biomarker in newborns that can predict the subsequent onset and severity of paediatric atopic eczema, a new study presented at the 31st European Academy of Dermatology and Venereology (EADV) Congress has shown. The Barrie...
2022-09-07 06:01
4648
FONDAZIONE PRADA PRESENTS "HUMAN BRAINS: PRESERVING THE BRAIN - FORUM ON NEURODEGENERATIVE DISEASES"
MILAN, Sept. 6, 2022 /PRNewswire/ -- "Human Brains" is the result of an in-depth research process undertaken by Fondazione Prada in 2018 in the field of neuroscience. The project has featured an online conference dedicated to the study of consciousness, a series of video talks by international sc...
2022-09-06 21:00
4439
Prospection partners with leading Japanese healthcare data provider Medical Data Vision to improve treatment access for patients
SYDNEY, Sept. 6, 2022 /PRNewswire/ -- Health analytics pioneer, Prospection has announced a unique global data access agreement with leading Japanese medical data company Medical Data Vision Co., Ltd. (MDV) to accelerate healthcare analytics globally. The agreement, covering the world's second...
2022-09-06 07:34
2966
Thailand heightens its healthcare hub ambition with integrative medicine
BANGKOK, Sept. 5, 2022 /PRNewswire/ -- Living with the COVID-19 pandemic, people start to recognize the equal importance of modern medicine and preventive practices in maintaining their good health and wellbeing. With a strong healthcare and wellness infrastructure and reputation for highly-skill...
2022-09-05 15:22
4981
FDA-approved Investigator-initiated Pre-market Clinical Trial of LAmbre™ Plus LAA Closure System Obtained Medical Insurance Coverage in the US
SHENZHEN, China, Sept. 5, 2022 /PRNewswire/ -- LifeTech Scientific Corporation (Stock Code: 1302.HK) is pleased to announce that on30 August 2022, an FDA-approved investigator-initiated pre-market clinical trial of its proprietary LAmbre™ Plus Left Atrial Appendage (LAA) Closure System has obtai...
2022-09-05 13:02
5886
Docquity raises US$44 million in series C round led by Itochu Corporation
New round of funding to bolster new expansion plans beyond the Southeast Asia region - inNorth Asia and the Middle East SINGAPORE, Sept. 5, 2022 /PRNewswire/ -- Singapore-based Docquity, Southeast Asia's largest community of healthcare professionals, announced today that it has raised a tot...
2022-09-05 10:00
5311
Innovent Announces First Participant Dosed in the Higher-dose Cohort of a Phase 2 Clinical Trial of Mazdutide in Chinese Adults with Obesity
ROCKVILLE, Md. and SUZHOU, China, Sept. 5, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...
2022-09-05 08:00
4354
Week's Top Stories
Most Reposted
Responsible Fintech Institute Appoints Four Executive Fellows and Elevates Distinguished Professor Patrick H. M. Loh to Co-Founder
[Picked up by 279 media titles]
2026-09-29 09:00
Zenika CTO Adrien Nortain Moves Base to Singapore to Strengthen Technical Leadership in Asia
[Picked up by 271 media titles]
2026-10-01 10:00
ViewSonic Launches VG1457 Dual-Screen Portable Monitor for Productivity Anywhere
[Picked up by 269 media titles]
2026-09-30 10:50
Vestas Powers Up Vietnam's Clean Energy Ambitions with Two New Projects Under PDP8 Totaling 16 Wind Turbines
[Picked up by 263 media titles]
2026-10-02 16:27
Sunway University to Host Asia's First Global Tipping Points Conference 2026
[Picked up by 263 media titles]
2026-09-30 12:11
Most Read
MixVio AI Launches Unified Creative Workspace Across 26 AI Generation Routes
2026-10-02 00:30
23754
